옵션 체인은 다양한 행사가격과 만기일에 대한 NuCana의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 NuCana에 대한 시장 심리를 평가합니다..

NuCana (NASDAQ:NCNA) 주식, 옵션 체인

NuCana

NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.

NuCana PLC

Amazon.com Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) autonomous vehicle company Zoox has reportedly recalled over 270 vehicles to rectify a software issue that led to a crash in Las Vegas, Nevada, on April 8, 2025.
What Happened: A Zoox robotaxi, which had no occupants at the time, crashed into a passenger vehicle in Las Vegas. However, no injuries were reported following the accident, Reuters reported on Tuesday.
Following the crash, the company had reportedly halted operations and initiated a safety review as well as developed a software update to rectify the issue, the report suggests.
Zoox says its software "may make an inaccurate prediction when another vehicle slowly approaches perpendicularly and stops. In these scenarios, the Zoox vehicle may not be able to avoid a crash.&#8221;
The AV company also conceded that the issue may occur at speeds greater than 40 miles per hour when a vehicle "incrementally encroaches" from a perpendicular driveway, the report said.
Why It Matters: The recall comes in as the autonomous vehicle sector in the U.S. is steadily gaining pace, with Alphabet Inc.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) Waymo leading the charge, followed by Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) and Zoox.&nbsp;
Waymo <a href="https://www.benzinga.com/markets/equities/25/04/45090602/google-backed-waymo-and-toyota-forge-strategic-partnership-to-bring-autonomous-driving-tech-to-personally-owned-vehicles">recently partnered</a> with Toyota Motor Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TM#NYSE">TM</a>) to collaborate on developing autonomous vehicles, with special focus on personal ownership. Tesla CEO Elon Musk also reaffirmed the company's <a href="https://www.benzinga.com/tech/25/05/45213809/teslas-elon-musk-says-manually-driven-cars-will-be-unusual-in-the-future-shares-updates-on-spacex-neuralink">June Robotaxi launch</a> in Austin.
Elsewhere, Uber Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) recently <a href="https://www.benzinga.com/markets/25/05/45162888/uber-heats-up-robotaxi-battle-against-tesla-waymo-with-may-mobility-deal">announced a partnership</a> with AV company May Mobility to operate thousands of robotaxis on the Uber platform. The company also <a href="https://www.benzinga.com/25/05/45214653/uber-could-win-the-robo-taxi-war-says-expert-analyst-predicts-75-gains-on-ride-hailing-cost-drop">got into an agreement</a> with German automaker Volkswagen AG (OTCPK: VLKAF) to operate VW ID. Buzz robotaxis in the U.S.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img loading="lazy" decoding="async" width="1024" height="194" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07060647/AMZN-MAY-7-2025-1024x194.jpg" alt="" class="wp-image-905243" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07060647/AMZN-MAY-7-2025-1024x194.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07060647/AMZN-MAY-7-2025-300x57.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07060647/AMZN-MAY-7-2025-768x145.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07060647/AMZN-MAY-7-2025-1536x290.jpg 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07060647/AMZN-MAY-7-2025.jpg 1629w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
AMZN scores well on Growth and Quality metrics and has satisfactory Momentum and Value scores. For more such insights, sign up for<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"> Benzinga Edge</a> today!
Check out more of Benzinga's Future Of Mobility coverage by<a href="https://www.benzinga.com/topic/mobility"> following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/05/45126638/tesla-will-own-the-autonomous-market-dan-ives-says-shrugging-off-waymo-toyota-agreement">Waymo-Toyota Tie-Up A Threat To Elon Musk&#8217;s Tesla? Dan Ives Dismisses It, Says &#8216;No One Can Compete With Their Scale And Scope&#8217;</a></li>
</ul>

News

Tech

AMZN

GOOG

GOOGL

TSLA

UBER

VLKAF

Amazon's Tesla Robotaxi Rival Zoox Recalls 270 Driverless Vehicles Following Las Vegas Crash In April: Report

WIIM

AMD shares are trading higher following better-than-expected Q1 financial results.

SEKEY

Epson Has Made A Strategic Investment In Blank Beauty Inc., A Knoxville-based Tech Platform That Enables On-demand, Customized Manufacturing Of Consumer Packaged Goods

ANET

Arista Networks shares are trading lower after the company reported a Q1 sales miss.

Taboola.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBLA#NASDAQ">TBLA</a>) sees Q2 sales of $438.000 million-$458.000 million vs $445.92 million analyst estimate.

Guidance

TBLA

Taboola.com Sees Q2 Sales $438.000M-$458.000M vs $445.92M Est

MRVL

Marvell shares are trading lower after the company postponed its Investor Day amid uncertainty.

Taboola.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBLA#NASDAQ">TBLA</a>) affirms FY2025 sales outlook from $1.84 billion-$1.89 billion to $1.84 billion-$1.89 billion vs $1.86 billion estimate.

Taboola.com Affirms FY2025 Sales Guidance of $1.84B-$1.89B vs $1.86B Est

WW International shares rae trading lower after the company voluntarily initiated a pre-packaged Chapter 11 bankruptcy filing in Delaware.

Taboola.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBLA#NASDAQ">TBLA</a>) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $0.05 by 40 percent. This is a 600 percent increase over earnings of $0.01 per share from the same period last year. The company reported quarterly sales of $427.49 million which beat the analyst consensus estimate of $418.97 million by 2.04 percent. This is a 3.26 percent increase over sales of $414.01 million the same period last year.

Earnings

Earnings Beats

Taboola.com Q1 Adj. EPS $0.07 Beats $0.05 Estimate, Sales $427.49M Beat $418.97M Estimate

RDWR

Radware Is Executing An Aggressive Strategy To Expand Its Market Presence And Accelerate Growth Across Its Cloud Services Business In The U.S

U.S. stock futures rose on Wednesday after two days of decline on Tuesday. Futures of major benchmark indices were higher in premarket.
The upmove comes after the U.S. and China <a href="https://www.benzinga.com/25/05/45242461/donald-trumps-trade-war-sparks-first-major-us-china-talks-scott-bessent-jamieson-greer-to-meet-chinese-delegation-in-geneva">agreed to hold high-level trade talks</a> in Switzerland this weekend, their first major meeting since President Donald Trump initiated the trade war, amid growing U.S. market concerns over tariff impacts. 
Investors will await the Federal Reserve&#8217;s decision on interest rates, which is slated to be announced by Fed Chair Jerome Powell today afternoon.
Meanwhile, the 10-year Treasury bond yielded 4.32% and the two-year bond was at 3.80%. The CME Group's FedWatch <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">tool</a>&#8216;s projections show markets pricing a 95.6% likelihood of the Federal Reserve keeping the current interest rates unchanged in its May meeting. 
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Change (+/-)</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-0.50%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-0.50%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>-0.51%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-0.91%</td>
</tr>
</tbody>
</table>
</figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, fell in premarket on Wednesday. The SPY was down 0.63% to $562.30, while the QQQ declined 0.65% to $484.55, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Cues From Last Session:
Only utilities and energy sectors advanced on Tuesday, while health care, industrials, and consumer discretionary sectors led the declines.
Fueled by businesses and consumers rushing to import goods before President Trump&#8217;s sweeping tariffs took effect, the U.S. trade deficit ballooned to a record $140.5 billion in March, according to the data released on Tuesday. Federal data revealed significant stockpiling, particularly of pharmaceuticals.
It approximately doubled from $68.6 billion in March 2024.
After Tuesday, the S&amp;P 500 index was out of the correction zone, just down 8.79% from its record high of 6,147.43 points, scaled on Feb. 19. Dow Jones was 9.42% lower than its 52-week high of 45,073.63 points, and Nasdaq 100 was 10.94% lower than its previous high of 22,222.61 points.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>-0.87%</td>
<td>17,689.66</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-0.77%</td>
<td>5,606.91</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-0.95%</td>
<td>40,829.00</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-1.50%</td>
<td>1,983.19</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts:
Ed Yaderni from Yardeni Research wrote in his QuickTakes memo that &#8220;A short bout of stagflation is likely.&#8221;
&#8220;We reckoned that the economy would remain resilient. We still think so, but Trump&#8217;s Tariff Turmoil (TTT) is stress-testing the resilience of the economy. It will probably slow economic growth and boost inflation. A short bout of stagflation is likely,&#8221; he added.
Nathan Peterson, director of derivatives analysis at the Schwab Center for Financial Research, said that the AI-led optimism was booming again despite tariff woes.
&#8220;The sentiment around the AI secular growth story feels like it&#8217;s been resurrected, and the market seems more sanguine around companies&#8217; ability to navigate the potential impact of tariffs,&#8221; he said.
According to Cooper Howard, director, fixed income strategy at the Schwab Center for Financial Research, &#8220;The Fed will likely try to signal they are on hold for the time being and want to wait for more clarity about how tariffs will or won't impact the economy,&#8221; said &#8220;The market's projecting three cuts this year, which has been pared back from earlier expectations.&#8221;
Upcoming Economic Data
Here&#8217;s what investors will keep an eye on Wednesday:
<ul>
<li>The FOMC meeting will begin at 2:00 p.m., and Fed Chairman Jerome Powell will deliver the verdict at a press conference at 2:30 p.m. ET.</li>
</ul>
<ul>
<li>Consumer credit for March will be out by 3:00 p.m. ET.</li>
</ul>
Stocks In Focus:
<ul>
<li>Walt Disney Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) rose 0.87% in premarket on Wednesday as it is expected to report earnings before the opening bell. Analysts expect a quarterly earnings of $1.20 per share on revenue of $23.14 billion.</li>
<li>Uber Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) was up 0.54% as Wall Street expects it to report earnings of 50 cents per share on revenue of $11.62 billion before the opening bell.</li>
<li>Owens Corning (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OC#NYSE">OC</a>) was 0.021% below the flatline ahead of its earnings before the opening bell. Analysts expect a quarterly earnings of $2.87 per share on revenue of $2.51 billion.</li>
<li>Johnson Controls International PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JCI#NYSE">JCI</a>) was 0.35% higher as Wall Street expects it to report earnings of 80 cents per share on revenue of $5.66 billion before the opening bell.</li>
<li>Advanced Micro Devices Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) rose 2.43% as it reported stronger-than-expected first-quarter financial results Tuesday after the bell. AMD said it expects second-quarter revenue of approximately $7.4 billion, plus or minus $300 million. Analysts are currently forecasting second-quarter revenue of $7.24 billion.</li>
<li>Arista Networks Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANET#NYSE">ANET</a>) declined 4.37% after posting mixed first-quarter results after Tuesday's closing bell. It reported quarterly earnings of 65 cents per share, which beat the analyst consensus estimate of 60 cents. Quarterly revenue came in at $2 billion, which missed the consensus estimate of $2.02 billion.</li>
<li>Corpay Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPAY#NYSE">CPAY</a>) rose 1.44% after AvidXchange agreed to be acquired by TPG in partnership with Corpay for $2.2 billion.</li>
<li>TPG Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPG#NASDAQ">TPG</a>) jumped 4.96% as it announced the acquisition of Acquire Peppertree Capital Management.</li>
<li>Marvell Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>) dropped 4.21% after it postponed its investor day, citing the macroeconomic environment.</li>
</ul>
Commodities, Gold, And Global Equity Markets:
Crude oil futures were trading higher in the early New York session by 0.80% to hover around $59.56 per barrel.
Gold Spot US Dollar fell 1.59% to hover around $3,376.07 per ounce. Its last record high stood at $3,500.33 per ounce. The U.S. Dollar Index spot was higher by 0.28% at the 99.5120 level.
Asian markets ended higher on Monday except Japan's Nikkei 225. India's S&amp;P BSE Sensex, Australia's ASX 200, China&#8217;s CSI 300, Hong Kong's Hang Seng, and South Korea's Kospi index rose. European markets were falling in early trade.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/05/45245696/smci-issues-strong-q4-revenue-outlook-expects-nvidias-blackwell-to-fuel-growth">SMCI Issues Strong Q4 Revenue Outlook, Expects Nvidia&#8217;s Blackwell To Fuel Growth</a></li>
</ul>
Photo courtesy: Shutterstock

Equities

Market Summary

Futures

Treasuries

Economics

Federal Reserve

Pre-Market Outlook

Markets

CPAY

US Stocks Likely To Open Higher Ahead Of Fed's Verdict On Interest Rates: 'A Short Bout Of Stagflation Is Likely,' Says Expert

GEO Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEO#NYSE">GEO</a>) is looking for Q2 GAAP EPS of $0.15-$0.17 vs $0.24 analyst estimate. sees sales of $615.000 million-$625.000 million vs $635.62 million analyst estimate.

GEO Group Sees Q2 GAAP EPS $0.15-$0.17 vs $0.24 Est; Sees Sales $615.000M-$625.000M vs $635.62M Est

Full Year 2025 Guidance
BeiGene is maintaining its full year 2025 revenue and expense guidance. Guidance is summarized below:
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">FY 20251</td>
</tr>
<tr>
<td colspan="2" rowspan="1">Total Revenue</td>
<td colspan="1" rowspan="1">$4.9 billion to $5.3 billion</td>
</tr>
<tr>
<td colspan="2" rowspan="1">GAAP Operating Expenses (R&amp;D and SG&amp;A)</td>
<td colspan="1" rowspan="1">$4.1 billion to $4.4 billion</td>
</tr>
<tr>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Additional:</td>
<td colspan="1" rowspan="1">GAAP Gross Margin Percentage in mid-80% range</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">
Positive Full Year GAAP Operating Income
Generation of Positive Cash Flow from Operations
</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
</tbody>
</table>
</figure>

CORRECTION: BeiGene Affirms FY2025 Sales Guidance of $4.90B-$5.30B Vs. $5.09B Estimate

Acushnet Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GOLF#NYSE">GOLF</a>) reported quarterly earnings of $1.62 per share which beat the analyst consensus estimate of $1.31 by 23.66 percent. This is a 20 percent increase over earnings of $1.35 per share from the same period last year. The company reported quarterly sales of $703.37 million which beat the analyst consensus estimate of $697.68 million by 0.82 percent. This is a 0.59 percent decrease over sales of $707.55 million the same period last year.

GOLF

Acushnet Hldgs Q1 EPS $1.62 Beats $1.31 Estimate, Sales $703.37M Beat $697.68M Estimate

OSCR

Oscar Health Affirms FY2025 Sales Guidance of $11.20B-$11.30B vs $11.18B Est

Earnings Misses

CORRECTION: BeiGene Q1 Adj. EPADS $1.22 Beats $(0.74) Estimate, Sales $1.12B Miss $1.14B Estimate

LifeStance Health Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LFST#NASDAQ">LFST</a>) sees Q2 sales of $332.000 million-$352.000 million vs $352.76 million analyst estimate.

LFST

LifeStance Health Gr Sees Q2 Sales $332.000M-$352.000M vs $352.76M Est

Oscar Health Q1 EPS $0.92 Beats $0.83 Estimate, Sales $3.05B Beat $2.86B Estimate

LifeStance Health Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LFST#NASDAQ">LFST</a>) affirms FY2025 sales outlook from $1.40 billion-$1.44 billion to $1.40 billion-$1.44 billion vs $1.42 billion estimate.

LifeStance Health Gr Affirms FY2025 Sales Guidance of $1.40B-$1.44B vs $1.42B Est

Walker & Dunlop Announced The Launch Of WDSuite, Its New Digital Experience Designed To Reduce Friction For Commercial Real Estate Professionals Throughout The Investment Lifecycle

Health Care

Press Releases

NuCana to Present at the Jefferies Global Healthcare Conference

NuCana Reports Second Quarter 2024 Financial Results and Provides Business Update

NuCana Announces Update for Phase 2 Randomized Colorectal Cancer Study

General

NuCana Presents Encouraging Data on NUC-7738 in Combination with Pembrolizumab in PD-1 Inhibitor Refractory and Resistant Melanoma Patients at the ESMO Congress 2024

Legal

NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in the United States

NuCana Announces Encouraging Initial Data from Phase 1b/2 Modular Study of NUC-3373 in Combination with Pembrolizumab or Docetaxel

NuCana Reports Third Quarter 2024 Financial Results and Provides Business Update

Aurion Biotech Appoints Donald Munoz as Chief Financial Officer

NuCana Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Update

NuCana Prices $7 Million Registered Direct Offering

NCNA

Aditxt

Apollomics

Aptevo Therapeutics

Bone Biologics

Entero Therapeutics

Genprex

GRI Bio

Lixte Biotechnology Holdings, Inc. - Common Stock

Lixte Biotechnology

Mustang Bio

Matinas Biopharma Holdings, Inc. Common Stock

Matinas BioPharma Hldgs

Onconetix

Psyence Biomedical Ltd. - Ordinary Shares

Psyence Biomedical

Plus Therapeutics

Protagenic Therapeutics, Inc. - Common Stock

Protagenic Therapeutics

Qualigen Therapeutics, Inc. - Common Stock

Qualigen Therapeutics

Revelation Biosciences, Inc. - Common Stock

Revelation Biosciences

Scinai Immunotherapeutics Ltd. - American Depositary Shares

Scinai Immunotherapeutics

Shuttle Pharmaceuticals Holdings, Inc. - common stock

Shuttle Pharmaceuticals

Salarius Pharmaceuticals, Inc. - Common Stock

Salarius Pharmaceuticals

Tharimmune

Windtree Therapeutics, Inc. - Common Stock

Windtree Therapeutics

ZyVersa Therapeutics, Inc. - Common Stock

ZyVersa Therapeutics

Oppenheimer

Truist Securities

Jefferies

Comments

NuCana

NuCana (NCNA) 옵션

No option chain data available. Please try again later

뉴스

파트너 / 기고자

벤징가 글로벌